Skip to Content
Merck
All Photos(1)

Documents

B-034

Supelco

Bupropion hydrochloride solution

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C13H19Cl2NO
CAS Number:
31677-93-7
Molecular Weight:
276.20
EC Number:
200-659-6
MDL number:
MFCD00055209
UNSPSC Code:
41116107
PubChem Substance ID:
329773108
NACRES:
NA.24

grade

certified reference material

Quality Level

300

form

liquid

feature

SNAP-N-SPIKE®, SNAP-N-SHOOT®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in methanol (as free base)

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

SMILES string

Cl.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1

InChI

1S/C13H18ClNO.ClH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H

InChI key

HEYVINCGKDONRU-UHFFFAOYSA-N

Gene Information

human ... SLC6A2(6530) , SLC6A3(6531)

Related Categories

General description

A certified solution standard suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing and pharmaceutical research. Bupropion is an antidepressant and smoking cessation drug sold under the trade names Wellbutrin® and Zyban®.

Application


  • Investigation of neurotoxic effects: Research on propofol′s potential neurotoxic impact on the hippocampus has deepened understanding of its effects on mitochondrial function. (Ebrahimi et al., 2024).

  • Enhancement of cardiopulmonary bypass outcomes: Propofol is used in clinical trials to explore its efficacy in reducing biomarkers of organ injury during cardiac surgery. (Smartt et al., 2024).

  • Development of nanoencapsulation techniques: Propofol is being researched for its encapsulation in nanocarriers to improve its delivery efficiency and reduce side effects. Such innovations in drug delivery are aimed at enhancing the pharmacological profile of anesthetics, making them safer and more effective (Abdoullateef et al., 2024).


Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Wellbutrin is a registered trademark of GlaxoSmithKline LLC
Zyban is a registered trademark of Everris International B.V.

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes,Central nervous system

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 2

1 of 2

Bromine reagent grade

Sigma-Aldrich

207888

Bromine

Ammonium hydroxide solution ACS reagent, 28.0-30.0% NH3 basis

Sigma-Aldrich

221228

Ammonium hydroxide solution

Marney A White et al.
The Journal of clinical psychiatry, 74(4), 400-406 (2013-05-10)
Binge-eating disorder (BED) is defined by recurrent binge eating (eating unusually large quantities of food during which a subjective loss of control is experienced), marked distress about the binge eating, and the absence of inappropriate weight compensatory behaviors. BED is
Paul M Cinciripini et al.
JAMA psychiatry, 70(5), 522-533 (2013-03-29)
Given the actions of varenicline tartrate and bupropion hydrochloride sustained-release (SR) on neurobiological targets related to affect and reward, it is thought that the modulation of nicotine withdrawal symptoms may contribute to their effectiveness. To assess the relative efficacy of
Kamran Siddiqi et al.
Annals of internal medicine, 158(9), 667-675 (2013-05-08)
Tobacco use is responsible for a large proportion of the total disease burden from tuberculosis. Pakistan is one of the 10 high-burden countries for both tuberculosis and tobacco use. To assess the effectiveness of a behavioral support intervention and bupropion
Daniel T Tsoi et al.
The Cochrane database of systematic reviews, 2(2), CD007253-CD007253 (2013-03-02)
Individuals with schizophrenia smoke more heavily than the general population and this contributes to their higher morbidity and mortality from smoking-related illnesses. It remains unclear what interventions can help them to quit or to reduce smoking. To evaluate the benefits
Leonie S Brose et al.
Mayo Clinic proceedings, 88(3), 226-233 (2013-03-16)
To compare the effectiveness of varenicline and combination nicotine replacement therapy (NRT) for treating smokers attempting to stop, as it is unclear which of the 2 is more effective. Data from 167,487 treatment episodes in patients from 42 National Health
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service